Fortress Biotech, Inc.

  • Home
  • About
    • Overview
    • Business Development
    • Management Team
    • Board of Directors
    • FAQ
  • Programs
    • Pipeline
    • Marketed Products
    • Publications
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • Analyst Coverage
    • SEC Filings
    • Governance
    • Resources
  • Contact
  • Careers
  • FAQ
  • Accessibility Statement

Press Releases

Investors

Investors

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Annual Meeting Materials
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Resources
    • FBIOP Announcements
  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Fortress Biotech to Participate in the Benzinga Healthcare Small Cap Conference

Sep 28, 2021

Mustang Bio Announces MB-101 (IL13Rα2‐targeted CAR T cells) Scientific Presentations at Upcoming Virtual Conferences

Sep 28, 2021

Checkpoint Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference

Sep 22, 2021

Mustang Bio to Participate in Three September 2021 Investor Conferences

Sep 09, 2021

Fortress Biotech to Participate in Three September 2021 Investor Conferences

Sep 09, 2021

Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences

Sep 09, 2021

Fortress Biotech Reports Record Second Quarter 2021 Financial Results and Recent Corporate Highlights

Aug 16, 2021

Mustang Bio Reports Second Quarter 2021 Financial Results and Recent Corporate Highlights

Aug 16, 2021

Mustang Bio Collaborates with Mayo Clinic on Novel CAR T Technology

Aug 12, 2021

Checkpoint Therapeutics Reports Second Quarter 2021 Financial Results

Aug 05, 2021
RSS
  • Prev
    • 1...
    • 29
    • 30
    • 31
    • 32
    • 33
    • 34
    • 35
    • 36
    • 37
    • 38
    • ...71
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    Fortress Biotech programs include product candidates in development at Fortress, its majority-owned and majority-controlled partner companies and entities in which it holds minority ownership positions.

    © 2025 Fortress Biotech, Inc. All Rights Reserved.
    Facebook Twitter Linkedin
    Accessibility Statement Privacy Policy Disclaimer Sitemap